Skip to main content

Table 6 CMR findings GPA

From: T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides

  Controls (n = 20) Patients (n = 15) p
LV-EF (%) 65 ± 4 68 ± 7 0.24
LV-EDV (ml) 109 ± 27 118 ± 28 0.57
LV-ESV (ml) 39 ± 13 39 ± 14 0.91
LV-SV 71 ± 15 80 ± 20 0.19
LV-EDD 45 ± 5 47 ± 4 0.36
LA (cm2) 20 ± 3 20 ± 3 0.71
IVS (mm) 10 ± 2 11 ± 2 0.11
PA (mm) 24 ± 4 24 ± 4 0.78
LV mass (g) 85 ± 20 92 ± 25 0.57
LGE per patient - 7 (47%)  
epicardial - 3 (20%)  
intramural - 4 (27%)  
transmural - -  
subendocardial - -  
% LV mass - 6.3 ± 4  
Native T1 (ms) 952 (923–960) 1002 (972–1023) <0.001
Post-contrast T1 (ms) 524 (500–529) 490 (477–551) 0.16
ECV (%) 24.5 (23–25) 27 (26–28) <0.001
T2 (ms) 49 (48–51) 53 (51–54) <0.001
  1. All values are n or mean ± SD or interquartile ranges. CMR cardiac magnetic resonance, LV left-ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume